2026-01-24 - Analysis Report
**Company Overview**
UnitedHealth Group is a multinational healthcare company providing health care benefits, pharmaceutical solutions, and health care services to the public sector.

**Return Rate Comparison**

| Ticker | Cumulative Return |
| --- | --- |
| UNH (Review Stock) | 41.97% |
| VOO (Comparison Stock) | 126.41% |
| Divergence | -84.40 (-13.80%) |

The review stock (UNH) underperformed the comparison stock (VOO) by 84.40% or 13.80% relative divergence.

**Alpha, Beta Analysis**

| Year      | CAGR | MDD  | Alpha | Beta | Cap(B) |
|-----------|------|------|-------|------|--------|
| 2016-2018 | 48.0% | 18.6% | 36.0% | 0.9  | 225.7B |
| 2017-2019 | 40.0% | 18.6% | 15.0% | 0.9  | 266.3B |
| 2018-2020 | 26.0% | 34.9% | 2.0%  | 1.1  | 317.7B |
| 2019-2021 | 84.0% | 34.9% | 18.0% | 1.1  | 454.9B |
| 2020-2022 | 87.0% | 34.9% | 80.0% | 0.9  | 480.3B |
| 2021-2023 | 50.0% | 15.9% | 30.0% | 0.5  | 476.9B |
| 2022-2024 | -22.0% | 21.7% | -52.0% | 0.4  | 458.2B |
| 2023-2025 | -89.0% | 59.4% | -165.0% | 0.3  | 299.0B |

**Recent Stock Price Fluctuations**

|  | Value |
| --- | --- |
| Close | $356.26 |
| Last-Market | $356.26 ($354.47 $0.5) |
| 5-day SMA | $345.59 |
| 20-day SMA | $339.34 |
| 60-day SMA | $332.91 |

**RSI, PPO Index Indicators and Delta_Previous_Relative_Divergence**

|  | Value |
| --- | --- |
| MRI (Market Risk Indicator) | 0.70 |
| RSI | 63.05 |
| PPO | 0.47 |
| Hybrid Signal | Buy |
| Risk Level | Medium |
| Relative Divergence Change | 3.60 (+) |
| 7-day Rank Change | 145 (+) |
| 7-day Dynamic Expected Return Change | 562.50 (+) |
| Expected Return | 204.70% |

**Recent Fluctuation Issues**
The recent price fluctuation of $1.79 (0.5%) may indicate a sharp rebound.

**Recent News & Significant Events**

* Don't Buy UnitedHealth Group Stock Before Jan. 27 - The Motley Fool
* Is UnitedHealth Stock (UNH) a Buy Ahead of Q4 Earnings? - TipRanks
* Dear UnitedHealth Stock Fans, Mark Your Calendars for January 27 - Yahoo Finance
* UnitedHealth rebating profits from ACA plans to customers (UNH:NYSE) - Seeking Alpha
* UnitedHealth Stock Climbs 7.3% as Reddit Rage Fades to Neutral - 24/7 Wall St.
* Buying UnitedHealth Before Q4 Earnings? Cost Pressures a Red Flag - Zacks Investment Research

**Analyst Opinions**

* Analyst Consensus:
  - Key: Buy
  - Mean (1=StrongBuy~5=Sell): 1.93 (~Buy)
  - Opinions: 26
  - Target Price (avg/high/low): $393.77 / $444.00 / $280.00

**Recent Earnings Analysis**

| Date | EPS | Revenue |
| --- | ---: | ---: |
| 2025-10-28 | 2.59 | $113.16 B |
| 2025-08-11 | 3.76 | $111.62 B |
| 2025-05-07 | 6.9 | $109.58 B |
| 2024-11-04 | 6.56 | $100.82 B |
| 2025-10-28 | 6.56 | $100.82 B |

**Financial Information = 5. Financial Information**

**Revenue and Profitability**

| Quarter | Revenue | Profit Margin |
|---------|----------|---------------|
| 2025-09-30 | $113.16B | 18.24% |
| 2025-06-30 | $111.62B | 17.93% |
| 2025-03-31 | $109.58B | 21.70% |
| 2024-12-31 | $100.81B | 21.14% |
| 2024-09-30 | $100.82B | 22.84% |

**Capital and Profitability**

| Quarter | Equity | ROE |
|---------|---------|-----|
| 2025-09-30 | $95.79B | 2.45% |
| 2025-06-30 | $94.72B | 3.60% |
| 2025-03-31 | $95.04B | 6.62% |
| 2024-12-31 | $92.66B | 5.98% |
| 2024-09-30 | $94.53B | 6.41% |

**Comprehensive Analysis (Summary of previous items)**

UnitedHealth Group's return rate has underperformed the S&P 500 by 84.40% or 13.80% relative divergence. The company's stock price has fluctuated, with a recent price change of $1.79 (0.5%). The MRI market risk indicator is at 0.70, indicating a medium risk level. Analysts recommend a buy rating with a target price of $393.77. The company's recent earnings have been strong, with an EPS of 2.59 in the latest quarter. However, the revenue and profit margin have been declining in the past quarters. The company's capital and profitability have also declined in the past quarters. Overall, UnitedHealth Group's performance is mixed, with both positive and negative trends.

**Disclaimer:** This report is for informational purposes only and does not constitute financial advice. Investment involves risk.